Tube Investments of India Limited Announces Rs 75 Crore Investment in Subsidiary 3xper Innoventure Limited
Tube Investments of India Limited announced an incremental investment of Rs 75 crore in subsidiary 3xper Innoventure Limited through CCPS subscription on 23rd April 2026. The investment is part of a Rs 100 crore fund raising initiative, with Mr. N Govindarajan contributing Rs 25 crore. 3xper operates in pharmaceutical Contract Development and Manufacturing Operations, and the funding will help scale up operations of the company and its subsidiary.

*this image is generated using AI for illustrative purposes only.
Tube investment has announced an incremental investment of Rs 75 crore in its subsidiary 3xper Innoventure Limited through subscription of Compulsorily Convertible Preference Shares (CCPS). The company entered into a supplementary agreement on 23rd April 2026 with 3xper Innoventure Limited and Mr. N Govindarajan for this strategic investment.
Investment Structure and Details
The total fund raising initiative amounts to Rs 100 crore, with Tube Investments of India Limited contributing Rs 75 crore and Mr. N Govindarajan investing Rs 25 crore. The investment will be made through subscription of CCPS at face value of Rs 100 per share.
| Investment Parameter: | Details |
|---|---|
| Total Investment: | Rs 100 crore |
| TII Investment: | Rs 75 crore |
| Mr. N Govindarajan Investment: | Rs 25 crore |
| CCPS Face Value: | Rs 100 per share |
| Total CCPS to be Issued: | 1 crore shares |
Current Shareholding Structure
3xper Innoventure Limited is a subsidiary of Tube Investments of India Limited. The company currently holds significant stakes in 3xper through both equity shares and preference shares.
| Current Holdings: | Details |
|---|---|
| Equity Shares: | 0.95 crore shares (Face value Rs 10 each) |
| Series A CCPS: | 284.05 crore shares (Face value Rs 100 each) |
| Relationship: | 3xper is a subsidiary of TII |
Business Operations and Strategic Purpose
3xper Innoventure Limited operates in the pharmaceutical industry with a focus on Contract Development and Manufacturing Operations (CDMO). The proposed fund raising is strategically designed to scale up the operations of 3xper and its subsidiary, enhancing their capabilities in the pharmaceutical manufacturing sector.
The investment represents a related party transaction as 3xper is a subsidiary of Tube Investments of India Limited. However, the CCPS subscription will be made at face value, ensuring transparent pricing for the transaction.
Regulatory Compliance
The disclosure has been made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and the SEBI Master Circular dated 30th January 2026. The closing of the transaction is subject to satisfactory completion of conditions precedent as contained in the supplementary agreement executed between the parties.
The supplementary agreement retains the significant terms of investment for CCPS while other terms remain as per the original agreement between the parties. This structured approach ensures continuity in the business relationship while facilitating the additional capital infusion required for expansion.
Historical Stock Returns for Tube Investment
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.83% | +7.84% | +20.14% | -7.41% | +11.06% | +165.75% |
How will this Rs 75 crore investment impact Tube Investments' overall financial leverage and capital allocation strategy across its diverse business portfolio?
What specific CDMO capabilities and market segments is 3xper targeting with this funding to compete against established pharmaceutical contract manufacturers?
Could this investment signal Tube Investments' broader pivot toward healthcare and pharmaceuticals as a new growth vertical beyond its traditional engineering businesses?


































